» Articles » PMID: 23574800

Achieving Valid Patient-reported Outcomes Measurement: a Lesson from Fatigue in Multiple Sclerosis

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2013 Apr 12
PMID 23574800
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The increasing influence of patient-reported outcome (PRO) measurement instruments indicates their scrutiny has never been more crucial. Above all, PRO instruments should be valid: shown to assess what they purport to assess.

Objectives: To evaluate a widely used fatigue PRO instrument, highlight key issues in understanding PRO instrument validity, demonstrate limitations of those approaches and justify notable changes in the validation process.

Methods: A two-phase evaluation of the 40-item Fatigue Impact scale (FIS): a qualitative evaluation of content and face validity using expert opinion (n=30) and a modified Delphi technique; a quantitative psychometric evaluation of internal and external construct validity of data from 333 people with multiple sclerosis using traditional and modern methods.

Results: Qualitative evaluation did not support content or face validity of the FIS. Expert opinion agreed with the subscale placement of 23 items (58%), and classified all 40 items as being non-specific to fatigue impact. Nevertheless, standard quantitative psychometric evaluations implied, largely, FIS subscales were reliable and valid.

Conclusions: Standard quantitative 'psychometric' evaluations of PRO instrument validity can be misleading. Evaluation of existing PRO instruments requires both qualitative and statistical methods. Development of new PRO instruments requires stronger conceptual underpinning, clearer definitions of the substantive variables for measurement and hypothesis-testing experimental designs.

Citing Articles

Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?.

Bharadia T, Vandercappellen J, Chitnis T, Eelen P, Bauer B, Brichetto G Mult Scler J Exp Transl Clin. 2022; 8(2):20552173221105642.

PMID: 35755007 PMC: 9228659. DOI: 10.1177/20552173221105642.


Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study.

Bencsik K, Dobos E, Jobbagy Z, Birkas A, Kovacs K, Satori M Pharmaceuticals (Basel). 2022; 15(5).

PMID: 35631424 PMC: 9145304. DOI: 10.3390/ph15050598.


The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus.

Morel T, Cano S, Bartlett S, Gordon C, Haier B, Regnault A Rheumatology (Oxford). 2021; 61(8):3329-3340.

PMID: 34897375 PMC: 9348773. DOI: 10.1093/rheumatology/keab920.


The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model.

Cleanthous S, Strzok S, Haier B, Cano S, Morel T Rheumatol Ther. 2021; 9(1):95-108.

PMID: 34622426 PMC: 8814226. DOI: 10.1007/s40744-021-00374-0.


Psychometric Analysis from EMBODY1 and 2 Clinical Trials to Help Select Suitable Fatigue PRO Scales for Future Systemic Lupus Erythematosus Studies.

Cleanthous S, Bongardt S, Marquis P, Stach C, Cano S, Morel T Rheumatol Ther. 2021; 8(3):1287-1301.

PMID: 34244970 PMC: 8380611. DOI: 10.1007/s40744-021-00338-4.